Pallas Health vs Gala: Clinician Picks vs Flat-Price Compounded Care

Quick verdict: Pallas Health vs Gala

When comparing Pallas Health vs Gala, Pallas emphasizes clinician choice between FDA-approved brand pens and compounded preparations with a first month from $139 for compounded semaglutide, while Gala advertises a flat all-inclusive compounded plan and a $220 promotion. If you want a clinician to choose brand or compounded medication, Pallas is best. If you prefer a single flat compounded price at every dose, Gala is built around that claim.

How they differ: pricing transparency and structure

Pallas Health lists specific pricing for both compounded and brand options. Compounded semaglutide is $139 first month then $597 every 12 weeks (a $199/mo average); compounded tirzepatide is $179 first month then $897 every 12 weeks (a $299/mo average). Brand-name Wegovy, Ozempic, Zepbound and Mounjaro are shown with cash-pay monthly figures. Pallas also notes that compounded plans are priced by medication rather than by milligram so titration does not raise the plan price.

Gala frames its offering as one flat price at every dose for compounded semaglutide and tirzepatide and advertises a $220 discount promotion, but the base dollar price was not visible on the captured page evidence. Gala emphasizes one flat price, provider visit and prescription included, and free two-day shipping.

Implications for users

Pallas supplies explicit first-month and renewal numbers and separates brand cash-pay figures. Gala promises a consistent flat price at every dose, but the specific base price was not exposed in the captured text.

Medication options and clinician role

Pallas Health offers both FDA-approved brand-name GLP-1s and clinician-personalized compounded semaglutide or tirzepatide, with eligibility determined by a US-licensed clinician. Pallas states a US-licensed clinician reviews your health history and personalizes the plan.

Gala offers compounded semaglutide and tirzepatide with a provider visit and prescription included. Gala presents its model as direct-pay telehealth with provider check-ins and home delivery. Both providers note that treatment is available only when a licensed clinician determines it is medically appropriate.

Shipping, delivery speed and convenience

Pallas advertises free expedited and free discreet shipping on every plan and a fully online experience that is asynchronous in most states (43 of 50 need no video visit), with a video visit required in seven states plus Washington, D.C.

Gala offers free two-day shipping and emphasizes no in-office visits. Both promote home delivery and no insurance billing, but Pallas specifies which states may require video visits while Gala does not present state visit requirements in the captured evidence.

Regulatory notes and what ‘‘compounded’’ means here

Both sources explicitly state that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Pallas adds that it does not manufacture or compound medications; compounded medications are prepared by US-licensed compounding pharmacies and the medication you receive may differ in appearance from any product shown on the site.

Patient experience and limitations

Pallas highlights a no membership fee model, a self-serve portal, a free companion app, weekday care-team hours, and a refund if a clinician decides treatment is not right. It also notes care-team hours are weekdays 9 AM to 5 PM ET and no emergency services are offered. Pallas is cash-pay only and does not bill insurance; FSA/HSA use may require a Letter of Medical Necessity.

Gala emphasizes no monthly membership, cancel anytime, and that there are no hidden fees. Gala also markets testimonial weight-loss figures but the captured content labels those as marketing and does not provide expanded FAQ details in the captured evidence.

Check Gala flat-price compounded plans and promotion

Conclusion and who should choose which

Across Pallas Health vs Gala the key tradeoffs are clinician flexibility and explicit pricing versus a flat-price compounded pitch and a promotional discount. Both offer compounded GLP-1s and both state that compounded medications are not FDA-approved. Pallas uniquely lists brand-name options and specific first-month and renewal prices and highlights clinician selection between brand and compounded therapy. Gala centers on one flat price at every dose, provider visit included, and a $220 promotion though the base price was not visible in the captured page text.

Choose Pallas Health if you want a US-licensed clinician to choose between FDA-approved brand-name pens and a clinician-personalized compounded preparation, and if you prefer explicit first-month and renewal pricing for compounded semaglutide or tirzepatide. Choose Gala if you prioritize a single flat compounded price at every dose with provider visit and prescription included and want the promotion or two-day shipping, but confirm the base price and renewal terms before enrolling.